carbamates has been researched along with Hallucination of Body Sensation in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 9.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
| "The observation that patients with Parkinson's disease dementia have extensive cholinergic deficits led to the hypothesis that cholinesterase inhibitors may provide benefits for patients with this condition." | 5.31 | Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. ( Bullock, R; Cameron, A, 2002) |
| "The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 5.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
| "Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits." | 1.32 | A case study in the treatment of dementia with Lewy bodies. ( Kaufer, DI, 2004) |
| "The observation that patients with Parkinson's disease dementia have extensive cholinergic deficits led to the hypothesis that cholinesterase inhibitors may provide benefits for patients with this condition." | 1.31 | Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. ( Bullock, R; Cameron, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishiro, H | 1 |
| Bullock, R | 1 |
| Cameron, A | 1 |
| Wobrock, T | 1 |
| Retz-Junginger, P | 1 |
| Retz, W | 1 |
| Supprian, T | 1 |
| Rösler, M | 1 |
| McKeith, IG | 2 |
| Wesnes, KA | 1 |
| Perry, E | 1 |
| Ferrara, R | 1 |
| Kaufer, DI | 1 |
| Reading, PJ | 1 |
| Luce, AK | 1 |
2 trials available for carbamates and Hallucination of Body Sensation
| Article | Year |
|---|---|
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Human | 2004 |
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
Topics: Aged; Carbamates; Caregivers; Cognition Disorders; Female; Follow-Up Studies; Hallucinations; Humans | 2001 |
4 other studies available for carbamates and Hallucination of Body Sensation
| Article | Year |
|---|---|
Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
Topics: Aged; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Japan; | 2014 |
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Hallucinations; Humans; Male; Parkins | 2002 |
[Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Topics: Affective Disorders, Psychotic; Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Carba | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galant | 2004 |